ESC 2018: Results from the VERDICT Trial

Published: 06 Sep 2018

  • Views:

    Views Icon 222
  • Likes:

    Heart Icon 0
Average (ratings)
No ratings
Your rating

Prof Thomas Engstrøm (University of Copenhagen, Copenhagen, DK) discusses very early vs deferred invasive evaluation using computerised tomography (VERDICT).

The purpose of the trial was to evaluate invasive therapy compared with delayed invasive therapy among patients with non–ST-segment elevation acute coronary syndrome (NSTE-ACS).

Filmed by Radcliffe Cardiology on site in Munich, ESC 2018.